NEUVIOR is the operating company. PHARMORIS is under controlled, non-production development. Work beyond that core is labelled by its present evidence, not its intended destination.
“What exists” records the present state. Each boundary states what the entry must not be taken to prove.
The Scottish company through which Varun is building a focused medicines-systems thesis.
What exists now
NEUVIOR Pharmaceuticals Ltd, incorporated in Scotland in 2025.
An operating company is not evidence of customers, deployment or clinical outcomes.
A staff-facing system intended to connect reviewable evidence, authorised decisions and accountable follow-through.
What exists now
A controlled, non-production development programme and two closed public funding records.
Not presented as deployed, clinically validated, NHS-backed or production-ready.
A discovery thesis around applied intelligence and robotics, developed only where a narrow buyer problem and governed data route can be evidenced.
What exists now
A defined discovery direction.
No customer, deployed product, revenue or partnership is claimed.
A predevelopment route that would use qualified external laboratories, CROs and CDMOs rather than implying owned facilities.
What exists now
Programme planning and diligence themes.
No site control, laboratory, manufacturing, pipeline ownership or regulated activity is claimed.
A research thesis for ground-based evidence qualification before any space or extreme-environment deployment.
What exists now
Exploratory research questions.
No mission, payload, partner, flight heritage or clinical capability is claimed.
Long-horizon concepts spanning technical softgoods, cultural design and new ways of describing time for lunar and planetary contexts.
What exists now
Named venture theses within Varun’s 2030 vision.
They are not presented as operating companies, products, partnerships or missions.